Platelet-Derived Growth Factor as Biomarker of Clinical Outcome for Autologous Platelet Concentrate Therapy in Grade I Knee Osteoarthritis
Michele Francesco Di Tolla,1,* Serena Romano,1,* Pietro Vassetti,2 Domenico Perugini,2 Immacolata Filoso,2 Serena Cabaro,1 Giusy Ferraro,1 Francesco Oriente,1 Giuseppe Perruolo,1 Flora Arvonio,3 Vittoria D’Esposito,4 Pietro Formisano1 1Department of Translational Medicine, University...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-03-01
|
| Series: | Biologics: Targets & Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/platelet-derived-growth-factor-as-biomarker-of-clinical-outcome-for-au-peer-reviewed-fulltext-article-BTT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849393075916374016 |
|---|---|
| author | Di Tolla MF Romano S Vassetti P Perugini D Filoso I Cabaro S Ferraro G Oriente F Perruolo G Arvonio F D’Esposito V Formisano P |
| author_facet | Di Tolla MF Romano S Vassetti P Perugini D Filoso I Cabaro S Ferraro G Oriente F Perruolo G Arvonio F D’Esposito V Formisano P |
| author_sort | Di Tolla MF |
| collection | DOAJ |
| description | Michele Francesco Di Tolla,1,* Serena Romano,1,* Pietro Vassetti,2 Domenico Perugini,2 Immacolata Filoso,2 Serena Cabaro,1 Giusy Ferraro,1 Francesco Oriente,1 Giuseppe Perruolo,1 Flora Arvonio,3 Vittoria D’Esposito,4 Pietro Formisano1 1Department of Translational Medicine, University of Naples “Federico II”, Naples, Italy; 2Pain Therapy HUB, Local Health Unit Napoli 2 Nord “San Giuliano” Hospital, Giugliano in Campania, Italy; 3NGmed srl, Naples, Italy; 4URT “Genomic of Diabetes”, Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore” – National Research Council (IEOMI-CNR), Naples, Italy*These authors contributed equally to this workCorrespondence: Pietro Formisano, Department of Translational Medicine, University of Naples “Federico II”, Naples, Italy, Email fpietro@unina.itIntroduction: Autologous platelet concentrates (APC) are widely used in the infiltrative treatment of knee osteoarthritis (OA) to enhance tissue healing and relieve pain. Aim of this study was to identify predictive biomarkers for clinical outcomes in patients with grade I knee OA.Methods: A panel of growth factors (GFs) and cytokines was determined in peripheral blood (PB) and APC. The Numeric Pain Rating Scale (NPRS) was used as a clinical readout before and after the APC infiltration.Results: A lower white blood cell (WBC) count and higher Monocyte-chemoattractant Protein-1 levels in PB were associated with APC-induced pain relief. Platelet-derived Growth Factor (PDGF) levels in APC were significantly higher in OA patients displaying a larger NPRS reduction, independent of platelet count. Finally, the simultaneous determination of PDGF, Vascular Endothelial Growth Factor, and Macrophage Inflammatory Protein-1α in APC discriminated OA patients with very poor or no response.Conclusion: Platelet-released GFs rather than platelet counts may predict clinical outcomes in grade 1 knee OA.Keywords: growth factors, cytokines, regenerative medicine, inflammation, pain relief |
| format | Article |
| id | doaj-art-246bd52e2d174010ad20e3e9e729f4e7 |
| institution | Kabale University |
| issn | 1177-5491 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Biologics: Targets & Therapy |
| spelling | doaj-art-246bd52e2d174010ad20e3e9e729f4e72025-08-20T03:40:34ZengDove Medical PressBiologics: Targets & Therapy1177-54912025-03-01Volume 19137147101474Platelet-Derived Growth Factor as Biomarker of Clinical Outcome for Autologous Platelet Concentrate Therapy in Grade I Knee OsteoarthritisDi Tolla MFRomano SVassetti PPerugini DFiloso ICabaro SFerraro GOriente FPerruolo GArvonio FD’Esposito VFormisano PMichele Francesco Di Tolla,1,* Serena Romano,1,* Pietro Vassetti,2 Domenico Perugini,2 Immacolata Filoso,2 Serena Cabaro,1 Giusy Ferraro,1 Francesco Oriente,1 Giuseppe Perruolo,1 Flora Arvonio,3 Vittoria D’Esposito,4 Pietro Formisano1 1Department of Translational Medicine, University of Naples “Federico II”, Naples, Italy; 2Pain Therapy HUB, Local Health Unit Napoli 2 Nord “San Giuliano” Hospital, Giugliano in Campania, Italy; 3NGmed srl, Naples, Italy; 4URT “Genomic of Diabetes”, Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore” – National Research Council (IEOMI-CNR), Naples, Italy*These authors contributed equally to this workCorrespondence: Pietro Formisano, Department of Translational Medicine, University of Naples “Federico II”, Naples, Italy, Email fpietro@unina.itIntroduction: Autologous platelet concentrates (APC) are widely used in the infiltrative treatment of knee osteoarthritis (OA) to enhance tissue healing and relieve pain. Aim of this study was to identify predictive biomarkers for clinical outcomes in patients with grade I knee OA.Methods: A panel of growth factors (GFs) and cytokines was determined in peripheral blood (PB) and APC. The Numeric Pain Rating Scale (NPRS) was used as a clinical readout before and after the APC infiltration.Results: A lower white blood cell (WBC) count and higher Monocyte-chemoattractant Protein-1 levels in PB were associated with APC-induced pain relief. Platelet-derived Growth Factor (PDGF) levels in APC were significantly higher in OA patients displaying a larger NPRS reduction, independent of platelet count. Finally, the simultaneous determination of PDGF, Vascular Endothelial Growth Factor, and Macrophage Inflammatory Protein-1α in APC discriminated OA patients with very poor or no response.Conclusion: Platelet-released GFs rather than platelet counts may predict clinical outcomes in grade 1 knee OA.Keywords: growth factors, cytokines, regenerative medicine, inflammation, pain reliefhttps://www.dovepress.com/platelet-derived-growth-factor-as-biomarker-of-clinical-outcome-for-au-peer-reviewed-fulltext-article-BTTgrowth factorscytokines: pain reliefregenerative medicineinflammation. |
| spellingShingle | Di Tolla MF Romano S Vassetti P Perugini D Filoso I Cabaro S Ferraro G Oriente F Perruolo G Arvonio F D’Esposito V Formisano P Platelet-Derived Growth Factor as Biomarker of Clinical Outcome for Autologous Platelet Concentrate Therapy in Grade I Knee Osteoarthritis Biologics: Targets & Therapy growth factors cytokines: pain relief regenerative medicine inflammation. |
| title | Platelet-Derived Growth Factor as Biomarker of Clinical Outcome for Autologous Platelet Concentrate Therapy in Grade I Knee Osteoarthritis |
| title_full | Platelet-Derived Growth Factor as Biomarker of Clinical Outcome for Autologous Platelet Concentrate Therapy in Grade I Knee Osteoarthritis |
| title_fullStr | Platelet-Derived Growth Factor as Biomarker of Clinical Outcome for Autologous Platelet Concentrate Therapy in Grade I Knee Osteoarthritis |
| title_full_unstemmed | Platelet-Derived Growth Factor as Biomarker of Clinical Outcome for Autologous Platelet Concentrate Therapy in Grade I Knee Osteoarthritis |
| title_short | Platelet-Derived Growth Factor as Biomarker of Clinical Outcome for Autologous Platelet Concentrate Therapy in Grade I Knee Osteoarthritis |
| title_sort | platelet derived growth factor as biomarker of clinical outcome for autologous platelet concentrate therapy in grade i knee osteoarthritis |
| topic | growth factors cytokines: pain relief regenerative medicine inflammation. |
| url | https://www.dovepress.com/platelet-derived-growth-factor-as-biomarker-of-clinical-outcome-for-au-peer-reviewed-fulltext-article-BTT |
| work_keys_str_mv | AT ditollamf plateletderivedgrowthfactorasbiomarkerofclinicaloutcomeforautologousplateletconcentratetherapyingradeikneeosteoarthritis AT romanos plateletderivedgrowthfactorasbiomarkerofclinicaloutcomeforautologousplateletconcentratetherapyingradeikneeosteoarthritis AT vassettip plateletderivedgrowthfactorasbiomarkerofclinicaloutcomeforautologousplateletconcentratetherapyingradeikneeosteoarthritis AT peruginid plateletderivedgrowthfactorasbiomarkerofclinicaloutcomeforautologousplateletconcentratetherapyingradeikneeosteoarthritis AT filosoi plateletderivedgrowthfactorasbiomarkerofclinicaloutcomeforautologousplateletconcentratetherapyingradeikneeosteoarthritis AT cabaros plateletderivedgrowthfactorasbiomarkerofclinicaloutcomeforautologousplateletconcentratetherapyingradeikneeosteoarthritis AT ferrarog plateletderivedgrowthfactorasbiomarkerofclinicaloutcomeforautologousplateletconcentratetherapyingradeikneeosteoarthritis AT orientef plateletderivedgrowthfactorasbiomarkerofclinicaloutcomeforautologousplateletconcentratetherapyingradeikneeosteoarthritis AT perruolog plateletderivedgrowthfactorasbiomarkerofclinicaloutcomeforautologousplateletconcentratetherapyingradeikneeosteoarthritis AT arvoniof plateletderivedgrowthfactorasbiomarkerofclinicaloutcomeforautologousplateletconcentratetherapyingradeikneeosteoarthritis AT despositov plateletderivedgrowthfactorasbiomarkerofclinicaloutcomeforautologousplateletconcentratetherapyingradeikneeosteoarthritis AT formisanop plateletderivedgrowthfactorasbiomarkerofclinicaloutcomeforautologousplateletconcentratetherapyingradeikneeosteoarthritis |